Issued Patents All Time
Showing 76–100 of 105 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7566696 | Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis | Hector F. DeLuca, Terrence F. Meehan, Bryan Becklund | 2009-07-28 |
| 7563783 | 2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2 | Hector F. DeLuca, Lori A. Plum | 2009-07-21 |
| 7550510 | Solid phase synthesis of arylretinamides | Robert W. Curley, Jr., Serena M. Mershon, Derek Barnett, Jason Chapman | 2009-06-23 |
| 7541348 | 2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol | Hector F. DeLuca, Lori A. Plum | 2009-06-02 |
| 7541349 | 2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone | Hector F. DeLuca, Lori A. Plum, Grazia Chiellini, Pawel Grzywacz | 2009-06-02 |
| 7538098 | 19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring | Hector F. DeLuca, Rafal R. Sicinski, Agnieszka Glebocka, Lori A. Plum | 2009-05-26 |
| 7534777 | Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3 | Hector F. DeLuca, Katarzyna Plonska-Ocypa, Rafal R. Sicinski, Pawel Grzywacz, Lori A. Plum | 2009-05-19 |
| 7534778 | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses | Hector F. DeLuca, Lori A. Plum | 2009-05-19 |
| 7528122 | Vitamin D analog—NEL, methods and uses thereof | Hector F. DeLuca, Grazia Chiellini, Pawel Grzywacz, Lori A. Plum | 2009-05-05 |
| 7528114 | C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth | Robert W. Curley, Jr., Joel R. Walker, Hussein Abou-Issa, Galal A. Alshafie | 2009-05-05 |
| 7511030 | 2-methylene-19-nor-(20S-24epi)-1α,25-dihydroxyvitamin D2 | Hector F. DeLuca, Lori A. Plum | 2009-03-31 |
| 7419992 | Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders | Hector F. DeLuca, Jiasheng Song, Stuart Helfand, Nasim Akhtar | 2008-09-02 |
| 7244719 | 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses | Hector F. DeLuca, Lori A. Plum, Pawel Grzywacz | 2007-07-17 |
| 7241749 | 2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Hector F. DeLuca, Lori A. Plum, Pawel Grzywacz | 2007-07-10 |
| 7241750 | 2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses | Hector F. DeLuca, Bulli Padmaja Tadi, Lori A. Plum | 2007-07-10 |
| 7241751 | 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses | Hector F. DeLuca, Rafal R. Sicinski, Lori A. Plum | 2007-07-10 |
| 7241752 | 17,20(E)-dehydro vitamin D analogs and their uses | Hector F. DeLuca, Bulli Padmaja Tadi, Lori A. Plum | 2007-07-10 |
| 7241909 | 19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds | Hector F. DeLuca, Pawel Grzywacz, Lori A. Plum | 2007-07-10 |
| 7241748 | 17,20(Z)-dehydro vitamin D analogs and their uses | Hector F. DeLuca, Bulli Padmaja Tadi, Lori A. Plum | 2007-07-10 |
| 7238681 | 2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses | Hector F. DeLuca, Rafal Barycki, Lori A. Plum | 2007-07-03 |
| 7235680 | 2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone | Hector F. DeLuca, Lori A. Plum, Grazia Chiellini, Pawel Grzywacz | 2007-06-26 |
| 7126017 | Method of reducing toxicity of retinoids | Hector F. DeLuca, Margaret A. Highland | 2006-10-24 |
| 6916834 | Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester | Hector F. DeLuca, Jiasheng Song, Richard E. Peterson, William M. Westler, Rafal R. Sicinski | 2005-07-12 |
| 6887860 | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses | Hector F. DeLuca, Lori A. Plum | 2005-05-03 |
| 6835723 | 2-methylene-19-nor-20(S)-1&agr;-hydroxy-bis-homo-pregnacalciferol in crystalline form | Hector F. DeLuca, James B. Thoden, Hazel Holden, Sumithra Gowlugari, Pawel Grzywacz | 2004-12-28 |